NCT07174388 An External Control Arm Study in Non-Small Cell Lung Cancer
| NCT ID | NCT07174388 |
| Status | Recruiting |
| Phase | — |
| Sponsor | N-Power Medicine |
| Condition | Non Small Cell Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 650 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2029-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 650 participants in total. It began in 2026-01-07 with a primary completion date of 2029-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A study to create control arms using current and future information in patients with lung cancer.
Eligibility Criteria
Inclusion Criteria: 1. \> 18 years of age at the time of informed consent 2. Pathologically confirmed locally advanced or metastatic NSCLC 3. ECOG Performance of less than or equal to 1 within 4 weeks prior to starting index therapy. 4. Life expectancy of more than 3 months 5. Able to understand and sign informed consent 6. Evidence of measurable disease (as assessed by the Investigator) on available imaging (e.g CT, MRI, PET) \*see protocol for cohort specific inclusion criteria\* Exclusion Criteria: 1. Actively on a clinical trial of an investigational agent 2. Currently receiving active systemic therapy for another malignancy 3. Eligible for treatment with curative intent \*see protocol for cohort specific exclusion criteria\*
Frequently Asked Questions
Who can join the NCT07174388 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non Small Cell Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07174388 currently recruiting?
Yes, NCT07174388 is actively recruiting participants. Visit ClinicalTrials.gov or contact N-Power Medicine to inquire about joining.
Where is the NCT07174388 trial being conducted?
This trial is being conducted at Monterey, United States, Dover, United States, Milford, United States, Barrington, United States and 4 additional locations.
Who is sponsoring the NCT07174388 clinical trial?
NCT07174388 is sponsored by N-Power Medicine. The trial plans to enroll 650 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.